Guogui Sun

机构：Hebei Medical University, North China University of Science and Technology, Tangshan College, North China University of Science and Technology Affiliated Hospital, TED University · ORCID：0000-0003-0348-0858

发表论文 111 篇 · 总被引 2300 次 · h-index 24

代表论文

• The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development (2023 · Journal for ImmunoTherapy of Cancer · 被引 80)
• Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study (2023 · BMC Medicine · 被引 34)
• SIRT4 Promotes Pancreatic Cancer Stemness by Enhancing Histone Lactylation and Epigenetic Reprogramming Stimulated by Calcium Signaling (2025 · Advanced Science · 被引 19)
• Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 16)
• Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers (2025 · Signal Transduction and Targeted Therapy · 被引 13)
• Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study (2024 · EClinicalMedicine · 被引 10)